218631-47-1 Usage
Uses
Used in Pharmaceutical Industry:
(1-(4-Methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl)methanol is used as a building block for the synthesis of pharmaceutical compounds. Its unique structure allows it to be a key component in the development of new drugs that may have potential applications in the treatment of various diseases.
Used in Agrochemical Industry:
In the agrochemical sector, (1-(4-Methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl)methanol is utilized in the development of new agrochemicals. It may serve as a component in the creation of pesticides or herbicides, contributing to more effective agricultural solutions.
Due to the lack of specific application reasons in the provided materials, the uses listed are based on the general potential of the compound in the respective industries. Further research and development would be required to pinpoint exact applications and reasons for its use in pharmaceutical and agrochemical settings.
Check Digit Verification of cas no
The CAS Registry Mumber 218631-47-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,8,6,3 and 1 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 218631-47:
(8*2)+(7*1)+(6*8)+(5*6)+(4*3)+(3*1)+(2*4)+(1*7)=131
131 % 10 = 1
So 218631-47-1 is a valid CAS Registry Number.
218631-47-1Relevant academic research and scientific papers
Discovery of 1-(2-Aminomethylphenyl)-3-trifluoromethyl-N-[3-fluoro-2′ -(aminosulfonyl)[1,1′-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor
Pruitt, James R.,Pinto, Donald J. P.,Galemmo Jr., Robert A.,Alexander, Richard S.,Rossi, Karen A.,Wells, Brian L.,Drummond, Spencer,Bostrom, Lori L.,Burdick, Debra,Bruckner, Robert,Chen, Haiying,Smallwood, Angela,Wong, Pancras C.,Wright, Matthew R.,Bai, Steven,Luettgen, Joseph M.,Knabb, Robert M.,Lam, Patrick Y. S.,Wexler, Ruth R.
, p. 5298 - 5315 (2007/10/03)
Factor Xa, a serine protease, is at the critical juncture between the intrinsic and extrinsic pathways of the coagulation cascade. Inhibition of factor Xa has the potential to provide effective treatment for both venous and arterial thrombosis. We recentl
INHIBITORS OF FACTOR XA WITH A NEUTRAL P1 SPECIFICITY GROUP
-
, (2008/06/13)
The present application describes inhibitors of factor Xa with a neutral P1 specificity group of formula I: STR1 or pharmaceutically acceptable salt forms thereof, wherein R and E may be groups such as methoxy and halo.
